VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,687,713 | -21.2% | 62,717 | -92.4% | 0.03% | -16.1% |
| Q2 2023 | $2,141,391 | +359.8% | 822,549 | +4962.2% | 0.03% | +287.5% |
| Q4 2022 | $465,696 | +9.3% | 16,249 | +4.5% | 0.01% | -20.0% |
| Q2 2022 | $426,000 | -29.8% | 15,549 | -1.8% | 0.01% | -23.1% |
| Q1 2022 | $607,000 | +39.9% | 15,833 | +16.9% | 0.01% | +30.0% |
| Q4 2021 | $434,000 | +23.3% | 13,549 | +13.4% | 0.01% | 0.0% |
| Q3 2021 | $352,000 | -11.6% | 11,949 | +2.1% | 0.01% | -9.1% |
| Q2 2021 | $398,000 | -32.8% | 11,699 | -35.8% | 0.01% | -42.1% |
| Q1 2021 | $592,000 | -13.2% | 18,215 | -3.8% | 0.02% | -20.8% |
| Q4 2020 | $682,000 | +128.1% | 18,935 | +148.2% | 0.02% | +84.6% |
| Q3 2020 | $299,000 | -21.1% | 7,630 | – | 0.01% | -18.8% |
| Q2 2020 | $379,000 | +86.7% | 0 | -100.0% | 0.02% | +60.0% |
| Q1 2020 | $203,000 | -10.2% | 8,830 | +14.2% | 0.01% | +11.1% |
| Q4 2019 | $226,000 | – | 7,730 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |